Viewing Study NCT02921802


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-02-26 @ 12:42 AM
Study NCT ID: NCT02921802
Status: COMPLETED
Last Update Posted: 2022-06-14
First Post: 2016-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Sponsor: Celgene
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NIS-Celgene-JP-PMS-001a
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators